We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KE
2226
Kimball Electronics
KE
$644M
| $708K | ﹤0.01% |
40,367
+211
| +0.5% | +$3.47K |
|
2227
GoPro
GPRO
$125M
| $706K | ﹤0.01% |
162,622
+2,117
| +1% | +$8.79K |
|
2228
Cerence
CRNC
$417M
| $705K | ﹤0.01% |
+31,138
| New | +$511K |
|
|
WTRE
2229
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $697K | ﹤0.01% |
27,712
+651
| +2% | +$17.3K |
|
|
CLVS
2230
DELISTED
Clovis Oncology, Inc.
CLVS
| $696K | ﹤0.01% |
66,788
+305
| +0.5% | +$2.22K |
|
|
OMN
2231
DELISTED
OMNOVA Solutions Inc.
OMN
| $693K | ﹤0.01% |
68,579
+582
| +0.9% | +$5.88K |
|
2232
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11B
| $691K | ﹤0.01% |
11,604
-6,000
| -34% | -$344K |
|
2233
CRA International
CRAI
$1.14B
| $689K | ﹤0.01% |
12,650
+178
| +1% | +$8.64K |
|
2234
Carriage Services
CSV
$657M
| $689K | ﹤0.01% |
26,920
+81
| +0.3% | +$1.97K |
|
|
COWN
2235
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $688K | ﹤0.01% |
43,685
+289
| +0.7% | +$4.34K |
|
|
PDLI
2236
DELISTED
PDL BioPharma, Inc.
PDLI
| $686K | ﹤0.01% |
211,460
-236
| -0.1% | -$685 |
|
|
SILK
2237
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $682K | ﹤0.01% |
16,898
+5,338
| +46% | +$187K |
|
|
ACBI
2238
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $682K | ﹤0.01% |
37,144
-117
| -0.3% | -$2.15K |
|
|
XRN
2239
Chiron Real Estate Inc
XRN
$464M
| $680K | ﹤0.01% |
10,287
+444
| +5% | +$27.9K |
|
2240
Dorian LPG
LPG
$1.84B
| $672K | ﹤0.01% |
43,418
+239
| +0.6% | +$3.15K |
|
|
ACRE
2241
Ares Commercial Real Estate
ACRE
$261M
| $666K | ﹤0.01% |
42,052
+224
| +0.5% | +$3.47K |
|
|
MOFG
2242
DELISTED
MidWestOne Financial Group
MOFG
| $665K | ﹤0.01% |
18,361
-62
| -0.3% | -$2.07K |
|
|
EGIO
2243
DELISTED
Edgio, Inc. Common Stock
EGIO
| $664K | ﹤0.01% |
4,069
+30
| +0.7% | +$4.75K |
|
|
HTB
2244
HomeTrust Bancshares
HTB
$869M
| $662K | ﹤0.01% |
24,684
+255
| +1% | +$6.7K |
|
|
CBL
2245
DELISTED
CBL& Associates Properties, Inc.
CBL
| $662K | ﹤0.01% |
630,455
+48,076
| +8% | +$62.9K |
|
2246
Tejon Ranch
TRC
$444M
| $661K | ﹤0.01% |
41,366
+971
| +2% | +$15.8K |
|
2247
Modine Manufacturing
MOD
$10.3B
| $657K | ﹤0.01% |
85,268
+2,827
| +3% | +$25.3K |
|
2248
Rayonier Advanced Materials
RYAM
$652M
| $657K | ﹤0.01% |
171,006
+6,781
| +4% | +$27.7K |
|
2249
Sierra Bancorp
BSRR
$528M
| $656K | ﹤0.01% |
22,520
+20
| +0.1% | +$549 |
|
2250
Weis Markets
WMK
$1.85B
| $656K | ﹤0.01% |
16,206
+165
| +1% | +$6.38K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.